IPCXR vs PATH · rev $100.0M vs P/E 19, rev $1.61B
Inflection Point Acquisition Corp. III Rights (IPCXR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Inflection Point Acquisition Corp. III Rights (IPCXR) common stock listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IPCXR revenue for 2025-09-30 was $100.0M. Net income was -$90.8K. IPCXR currently screens at market cap $0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IPCXR currently screens at market cap $0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IPCXR and PATH stock pages for the full models.
Not investment advice.